Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

NCT06488118 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Innate Immunity
Mucosal Immunity
Asthma
Viral Infection

Interventions

DRUG: R848
DRUG: Saline

Sponsor

Akhilesh Jha

Collaborators

[object Object]